John P. Moore, PhD, has studied antiviral antibodies and how vaccines can trigger their production for more than 30 years. He is a professor of microbiology and immunology at Weill Cornell Medicine in New York City. Melissa Cushing, MD, is the medical director of transfusion medicine and vice chair of laboratory medicine at New York-Presbyterian Hospital, Weill Cornell Campus. She is the principal investigator for the New York Coordinating Center of CONCOR-1, one of the largest Covid-19 convalescent plasma randomized clinical trials in the world. The opinions expressed in this commentary are the authors'. View more opinion on CNN. (CNN) The Food and Drug Administration's shocking decision this week to allow the use of Covid-19 convalescent plasma to treat sick patients was by all appearances motivated by a desire to appease President Donald Trump rather than on any serious consideration of the science. FDA Commissioner Stephen Hahn left the ...